Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.9 USD | -1.76% | -0.51% | -31.70% |
Financials (USD)
Sales 2024 * | 47.81M | Sales 2025 * | 64.33M | Capitalization | 1.14B |
---|---|---|---|---|---|
Net income 2024 * | -190M | Net income 2025 * | -219M | EV / Sales 2024 * | 20 x |
Net cash position 2024 * | 183M | Net cash position 2025 * | 79.31M | EV / Sales 2025 * | 16.5 x |
P/E ratio 2024 * |
-6.44
x | P/E ratio 2025 * |
-6.26
x | Employees | 586 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.9% |
Latest transcript on AbCellera Biologics Inc.
1 day | -1.76% | ||
1 week | -0.51% | ||
Current month | -13.91% | ||
1 month | -15.03% | ||
3 months | -25.86% | ||
6 months | -12.36% | ||
Current year | -31.70% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 39 | 12-11-07 | |
Founder | - | 12-11-07 | |
Carl Lars Hansen
CEO | Chief Executive Officer | 49 | 12-11-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Montalbano
BRD | Director/Board Member | 59 | 20-10-31 |
Michael Hayden
BRD | Director/Board Member | 72 | 19-09-30 |
Andrew Lo
BRD | Director/Board Member | 63 | 21-12-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.19% | 0 M€ | 0.00% | - | |
0.18% | 0 M€ | 0.00% | - | |
0.06% | 2 M€ | -.--% | ||
0.02% | 9 M€ | +6.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 3.9 | -1.76% | 1,599,034 |
24-04-23 | 3.97 | -1.00% | 1,595,129 |
24-04-22 | 4.01 | +3.62% | 1,076,281 |
24-04-19 | 3.87 | -1.02% | 978,622 |
24-04-18 | 3.91 | -0.26% | 765,647 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.70% | 1.16B | |
+4.09% | 43.43B | |
+47.81% | 41.69B | |
+9.45% | 41.31B | |
-10.92% | 27.14B | |
+9.32% | 25.28B | |
-24.87% | 18.47B | |
+29.70% | 12.59B | |
+1.28% | 12.33B | |
+7.78% | 11.03B |
- Stock Market
- Equities
- ABCL Stock